StockWatch
·

NUCLEUS SOFTWARE EXPORTS LTD.

BSE: 531209

P/L Snapshot

Q1 FY2027 · standalone

vs Q4 FY2026
Revenue
211.43
-4.6%
Expenditure
192.50
+7.9%
Net Profit
22.95
-31.4%
OPM %
8.35%
-6.24pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0064.27128.53192.80257.06Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027

Price Chart

Latest News

Board Meeting30 Jul, 4:18 pm

Nucleus Q1 PAT falls 32% YoY to ₹23.9 Cr — far worse ex a ₹9.8 Cr one-off; margins squeezed

Nucleus Software's Q1 FY27 (consolidated) was a weak print across every operating line. Revenue from operations of ₹210.4 Cr fell 3.3% YoY and 6.4% sequentially, and net profit of ₹23.9 Cr dropped 32% YoY — yet even that flatters the quarter, because it carries a ₹9.8 Cr exceptional GAIN (a gratuity and compensated-absences provision write-back) that the year-ago quarter did not have. Strip it out and underlying PAT is only ~₹16 Cr, roughly 54% below last year's ₹35.2 Cr. Profit before exceptional items and tax collapsed 58% YoY to ₹20.3 Cr — that, not the reported number, is the real read on the quarter. The compression sits squarely on costs against a shrinking top line. Employee benefit expense rose 8% YoY to ₹157.2 Cr and operating/other expenses climbed 19% to ₹45.3 Cr while revenue actually fell, dragging net margin to ~11.4% from ~16.2% a year ago. Management had itself warned on the prior call that employee costs would stay elevated (team investments plus the new labour codes), and this quarter confirms that — but revenue did not grow to absorb it. The one-off gain is the mirror image of the ₹22 Cr labour-code provision Nucleus booked in FY26; a remuneration-structure change let it release part of that provision this quarter. The company gives no formal revenue guidance, and the ₹1,044 Cr order book management pointed to last quarter as a forward lever has not yet reached the P&L — India revenue slipped to ₹118.1 Cr and only the Middle East and Far East geographies grew, while South East Asia stayed loss-making at −₹6.6 Cr segment PBT. There is no published sell-side consensus for this smallcap, so there is no street bar to grade against. Alongside the result, the board's ₹12.50/share FY26 final dividend was paid on 28 July, and the company disclosed a ₹47 lakh GST demand it intends to appeal. The standalone numbers tell the same story (PAT ₹22.95 Cr, EPS ₹8.72), with the standalone-vs-consolidated divergence small enough not to change the conclusion.

30 Jul 2026, 04:18 pm

Corporate Events

Board MeetingNUCLEUS
2026
30Jul

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing
Board MeetingNUCLEUS
2026
27Jul

Board Meeting

The Thirty-Seventh (37th) Annual General Meeting of Nucleus …

BSE Filing
DividendNUCLEUS
2026
10Jul

₹12.5 / share

BSE Filing
Board MeetingNUCLEUS
2026
21May

Board Meeting

The Board of Directors had recommended a final dividend for …

BSE Filing
Board MeetingNUCLEUS
2026
10Feb

Board Meeting

Approval and Adoption of the Audited Standalone Financial re…

BSE Filing
Board MeetingNUCLEUS
2025
31Jul

Board Meeting

Approval and Adoption of the Audited Standalone Financial re…

BSE Filing
DividendNUCLEUS
2025
11Jul

₹12.5 / share

BSE Filing
Board MeetingNUCLEUS
2025
16May

Board Meeting

For Approval and Adoption of the Audited Standalone Financia…

BSE Filing
Board MeetingNUCLEUS
2025
28Jan

Board Meeting

Approval and Adoption of Audited Standalone Financial result…

BSE Filing
Board MeetingNUCLEUS
2024
12Nov

Board Meeting

Approval and Adoption of Audited Standalone Financial result…

BSE Filing
Board MeetingNUCLEUS
2024
22Aug

Board Meeting

BuyBack Of Equity Shares Of The Company

BSE Filing
Board MeetingNUCLEUS
2024
3Aug

Board Meeting

Approval and Adoption of Audited Standalone Financial result…

BSE Filing
Board MeetingNUCLEUS
2024
23May

Board Meeting

For Approval and Adoption of the Audited Standalone and Cons…

BSE Filing
Board MeetingNUCLEUS
2024
12Feb

Board Meeting

Approval and Adoption of Audited Standalone Financial result…

BSE Filing
Board MeetingNUCLEUS
2023
9Nov

Board Meeting

Approval and Adoption of Audited Standalone Financial result…

BSE Filing